Health
New drug class effective in treating certain types of ovarian cancers – News-Medical.Net
A study published today in Nature Communications shows that the drug rucaparib has been effective in treating certain types of ovarian cancers if used early in…
A study published today in Nature Communications shows that the drug rucaparib has been effective in treating certain types of ovarian cancers if used early in treatment, after a diagnosis, and before the cancer cells build up a resistance to chemotherapy.
Rucaparib is in a relatively new class of drugs – Poly(ADP-ribose) polymerase or PARP inhibitors – which have been approved for therapy in ovarian cancers. This study provides insights into both how the cancers resist treatments, and which patients…
-
Noosa News20 hours agoBob Katter threatens to punch Nine reporter during ant-immigration press conference
-
Business23 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business20 hours agoDicker Data rides the AI trend to double digit growth
-
Business23 hours agoForget CBA shares, this ASX 200 financials stock could be a better buy